Vaccine · San Francisco area, CA
Vaccine studies in San Francisco area, CA
16 recruiting studies have a site in the San Francisco area. This page includes nearby cities such as Oakland, Berkeley, San Mateo, Palo Alto.
16 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1
A Study to Learn About a Vaccine Against E Coli in Healthy Adults
Pfizer
- Location
- Anaheim, CA + 9 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
Kara Chew
- Location
- Los Angeles, CA + 1 other US site
- Eligibility basics
- Ages 40–64
- RecruitingHealthy volunteersPhase 3
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Pfizer
- Location
- Los Angeles, CA + 76 other US sites
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteersPhase 3
A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults
Pfizer
- Location
- Lake Forest, CA + 36 other US sites
- Eligibility basics
- Ages 18–49
- RecruitingHealthy volunteersPhase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Pfizer
- Location
- Daly City, CA + 138 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteersPhase 3
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Pfizer
- Location
- Lancaster, CA + 111 other US sites
- Eligibility basics
- Ages 0 mo–49
- RecruitingHealthy volunteersPhase 3
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
GlaxoSmithKline
- Location
- Dublin, CA + 130 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteersPhase 4
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
BioNTech SE
- Location
- Walnut Creek, CA + 4 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 3
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age
GlaxoSmithKline
- Location
- Walnut Creek, CA + 14 other US sites
- Eligibility basics
- Ages 1–6
- RecruitingHealthy volunteersPhase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
GlaxoSmithKline
- Location
- Canoga Park, CA + 46 other US sites
- Eligibility basics
- Ages 1–1
- RecruitingHealthy volunteersPhase 2
A Study to Learn About mRNA Vaccines Against Influenza in Adults
Pfizer
- Location
- Walnut Creek, CA + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Kaiser Permanente
- Location
- Oakland, CA
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteers
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Stanford University
- Location
- Palo Alto, CA
- Eligibility basics
- Ages 9–64
- RecruitingHealthy volunteersPhase 4
Safety of RSV Preventive Monoclonal Antibody
Duke University
- Location
- Oakland, CA + 4 other US sites
- Eligibility basics
- Ages 1 mo–7 mo
- RecruitingHealthy volunteers
A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults
University of California, San Francisco
- Location
- San Francisco, CA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Vaccine Confidence and Infodemic in Southeast Asia's Nusantara Sociocultural Sphere
University of California, Berkeley
- Location
- Berkeley, CA
- Eligibility basics
- Ages 18+
Who these studies look for
Vaccine studies often exclude people who recently received a related vaccine or had the infection, and those with conditions or medicines that affect the immune system.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.